| Application no. and date | 14824107.8 (espacenet) (Federated) (European Patent Register), 20141202 | | Patent/reg. no. and date | DK/EP 3077389, 20170913 | | Publication date | 20161012 | | Priority no. and date | WO PCT/IB2013/060596, 20131203 | | EP pub. no. and date |
EP 3077389 20161012 | | Effective date | | | Applicant/owner | Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91
4123 Allschwil, CH | | Applicant ref. no. | P62919DK01 | | Inventor | GUDE, Markus, Grabenring 9
CH-4123 Allschwil, CH,
BOSS, Christoph, c/o Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
CH-4123 Allschwil, CH,
BROTSCHI, Christine, c/o Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
CH-4123 Allschwil, CH,
SIFFERLEN, Thierry, c/o Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
CH-4123 Allschwil, CH,
VON RAUMER, Markus, c/o Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
CH-4123 Allschwil, CH,
HEIDMANN, Bibia, c/o Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
CH-4123 Allschwil, CH,
WILLIAMS, Jodi, T., c/o Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
CH-4123 Allschwil, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/4192 (2006.01) , A61P 25/00 (2006.01) , C07D 403/14 (2006.01) | | Title | KRYSTALLINSK FORM AF (S)-(2-(6-CHLOR-7-METHYL-1H-BENZO[D]IMIDAZOL-2-YL)-2-METHYLPYRROLIDIN-1-YL)(5-METHOXY-2-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)METHANON OG DENS ANVENDELSE SOM OREXINRECEPTORANTAGONISTER | | Int. application no. | IB2014066508 | | Int. publication no. | WO2015083070 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
